CVS plans pharmacy spinoff while keeping Aetna and Caremark together

What This is

• CVS Health plans to separate into two publicly traded companies in the first half of 2028, subject to final board approval and other closing conditions.
• The remaining CVS Health company would keep Aetna, Caremark, CVS Specialty, and healthcare providers Oak Street Health and Signify Health.
• The new CVS Pharmacy company would include about 9,000 retail stores, mail-order pharmacy operations, MinuteClinic, and the Health100 technology business.
• CVS expects the two companies to preserve shared products and services through commercial agreements after the split.
• Executives framed the breakup as a way for each business to become more focused and faster-moving.
• The move comes amid growing political and regulatory scrutiny of companies that combine insurers, pharmacy-benefit managers, and pharmacies.
• CVS also reported stronger-than-expected quarterly earnings and raised its annual profit outlook when announcing the separation.

Why This Matters

• The split could change how responsibility is divided over insurance coverage, drug pricing decisions, and prescription dispensing.
• It could influence how states and lawmakers approach other healthcare companies that combine insurers, drug-benefit managers, and pharmacies.
• It could shift bargaining power over drug costs and pharmacy payments, potentially affecting premiums, copays, and patients’ pharmacy choices.
• The outcome will test whether separate businesses make it easier for patients to resolve service problems and hold the responsible company accountable.